Symptoms and health-related quality of life in Japanese patients with primary biliary cholangitis
Minami Yagi(Teikyo University), Hajime Takikawa(Teikyo University), Satoshi Yamagiwa(Niigata University), Hiromasa Ohira(Fukushima Medical University), Tadashi Namisaki(Nara Medical University), Tetsuya Yasunaka(Okayama University), Atsushi Takahashi(Fukushima Medical University), Atsushi Tanaka(Medizinische Hochschule Hannover), Akinobu Takaki(Okayama University), Yoshiyuki Ueno(Yamagata Prefectural University of Health Sciences), Masanori Abe(Ehime University), Atsumasa Komori, Kentaro Kikuchi(Teikyo University), Yasushi Matsuzaki(Hirosaki University), Akira Honda(Rutgers, The State University of New Jersey), Hitoshi Yoshiji(Nara Medical University)
Cited by 30
Related Papers
Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines
|Journal of Hepato-Biliary-Pancreatic Surgery|2007|489
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
|Hepatology|2006|365
Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver.
|PubMed|1994|290
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272